This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Cañas F, Pérez-Solá V, Díaz S, Rejas J.Cost-effectiveness analysis of ziprasidone versus haloperidol in sequential intramuscular/oral treatment of exacerbation of schizophrenia. Clinical Drug Investigation 27: 633-645, No. 9, 2007
Rights and permissions
About this article
Cite this article
Ziprasidone good value for schizophrenia exacerbations. Pharmacoecon. Outcomes News 535, 1 (2007). https://doi.org/10.2165/00151234-200705350-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200705350-00001